$3.59 Billion is the total value of Broadfin Capital, LLC's 179 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 29.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Buy | ISHARES TRput | $436,800,000 | +99.9% | 4,000,000 | +128.6% | 24.30% | +107.0% |
HZNP | Buy | HORIZON PHARMA PLC | $132,108,000 | -21.0% | 6,665,391 | +38.4% | 7.35% | -18.2% |
NVRO | Buy | NEVRO CORP | $74,553,000 | +230.6% | 1,607,085 | +283.0% | 4.15% | +242.2% |
FLML | Sell | FLAMEL TECHNOLOGIES SAsponsored adr | $71,674,000 | -32.0% | 4,394,464 | -11.7% | 3.99% | -29.6% |
XBI | Buy | SPDR SERIES TRUSTput | $62,250,000 | -13.4% | 1,000,000 | +250.9% | 3.46% | -10.4% |
RTRX | Buy | RETROPHIN INC | $52,874,000 | -26.3% | 2,609,790 | +20.7% | 2.94% | -23.6% |
PGNX | PROGENICS PHARMACEUTICALS IN | $51,201,000 | -23.3% | 8,951,169 | 0.0% | 2.85% | -20.6% | |
EBS | Sell | EMERGENT BIOSOLUTIONS INC | $46,206,000 | -20.3% | 1,621,832 | -7.9% | 2.57% | -17.5% |
HRTX | Sell | HERON THERAPEUTICS INC | $45,433,000 | -39.2% | 1,862,001 | -22.3% | 2.53% | -37.0% |
ANGO | ANGIODYNAMICS INC | $31,637,000 | -19.6% | 2,398,527 | 0.0% | 1.76% | -16.7% | |
AEGR | Sell | AEGERION PHARMACEUTICALS INC | $31,557,000 | -41.7% | 2,320,366 | -18.7% | 1.76% | -39.6% |
LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $30,440,000 | +63.5% | 1,095,373 | +44.2% | 1.69% | +69.4% |
BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $26,377,000 | -6.5% | 4,744,060 | +33.9% | 1.47% | -3.2% |
REPH | Buy | RECRO PHARMA INC | $24,783,000 | +35.7% | 2,060,086 | +45.7% | 1.38% | +40.6% |
NVDQ | Buy | NOVADAQ TECHNOLOGIES INC | $19,907,000 | +213.8% | 1,908,648 | +264.3% | 1.11% | +224.9% |
RXDX | IGNYTA INC | $19,812,000 | -41.8% | 2,256,546 | 0.0% | 1.10% | -39.8% | |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $19,379,000 | +8.0% | 789,710 | +3.1% | 1.08% | +11.8% |
PTX | Buy | PERNIX THERAPEUTICS HLDGS IN | $19,247,000 | -35.9% | 6,090,829 | +20.0% | 1.07% | -33.7% |
CSII | New | CARDIOVASCULAR SYS INC DEL | $19,008,000 | – | 1,200,000 | +100.0% | 1.06% | – |
ADXS | Buy | ADVAXIS INC | $17,768,000 | -39.7% | 1,736,834 | +19.8% | 0.99% | -37.6% |
IDRA | Sell | IDERA PHARMACEUTICALS INC | $17,467,000 | -16.9% | 5,213,979 | -7.9% | 0.97% | -13.9% |
CORI | Buy | CORIUM INTL INC | $16,850,000 | -18.2% | 1,802,092 | +19.8% | 0.94% | -15.3% |
MASI | New | MASIMO ORD | $16,262,000 | – | 421,728 | +100.0% | 0.90% | – |
SPNE | New | SEASPINE HLDGS CORP | $16,200,000 | – | 1,000,007 | +100.0% | 0.90% | – |
KMPH | Sell | KEMPHARM INC | $15,500,000 | +1.9% | 799,788 | -3.4% | 0.86% | +5.5% |
SPPI | Sell | SPECTRUM PHARMACEUTICALS | $15,050,000 | -17.0% | 2,516,748 | -5.0% | 0.84% | -14.1% |
EGLTQ | Buy | EGALET CORP | $14,956,000 | +138.4% | 1,134,750 | +161.0% | 0.83% | +146.9% |
IG | IGI LABS | $14,962,000 | +3.8% | 2,287,728 | 0.0% | 0.83% | +7.4% | |
ZGNX | New | ZOGENIX INC | $14,947,000 | – | 1,107,205 | +100.0% | 0.83% | – |
AMPH | Sell | AMPHASTAR PHARMACEUTICALS IN | $14,928,000 | -40.1% | 1,276,979 | -9.9% | 0.83% | -38.0% |
ATRS | Buy | ANTARES PHARMA INC | $14,408,000 | -8.6% | 8,475,000 | +11.9% | 0.80% | -5.3% |
RIGL | Sell | RIGEL PHARMACEUTICALS INC | $12,659,000 | -32.9% | 5,125,282 | -12.8% | 0.70% | -30.6% |
CPRX | CATALYST PHARMACEUTICALS INC | $12,550,000 | -27.4% | 4,183,177 | 0.0% | 0.70% | -24.8% | |
HTWR | New | HEARTWARE INTERNATIONAL | $12,537,000 | – | 239,675 | +100.0% | 0.70% | – |
HRTX | New | HERON THERAPEUTICS INCcall | $12,200,000 | – | 500,000 | +100.0% | 0.68% | – |
LBIO | Buy | LION BIOTECHNOLOGIES INC | $12,128,000 | -27.0% | 2,105,519 | +16.2% | 0.68% | -24.4% |
MDGN | Buy | MEDGENICS INC | $12,084,000 | +77.0% | 1,545,306 | +38.7% | 0.67% | +83.1% |
QLTI | QLT INC | $11,825,000 | -35.6% | 4,445,527 | 0.0% | 0.66% | -33.3% | |
TRVN | Sell | TREVENA INC | $11,159,000 | +26.5% | 1,078,132 | -23.5% | 0.62% | +31.0% |
DSCI | Buy | DERMA SCIENCES INC | $11,126,000 | -32.9% | 2,362,104 | +1.9% | 0.62% | -30.6% |
PETX | Buy | ARATANA THERAPEUTICS INC | $11,081,000 | -35.3% | 1,309,865 | +15.7% | 0.62% | -32.9% |
PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0 | $10,816,000 | -21.8% | 15,500,000 | 0.0% | 0.60% | -19.1% | ||
RDHL | Buy | REDHILL BIOPHARMA LTDsponsored ads | $10,714,000 | +58.3% | 829,906 | +116.0% | 0.60% | +63.7% |
SPNC | New | SPECTRANETICS CORP | $10,614,000 | – | 900,249 | +100.0% | 0.59% | – |
MRTX | Sell | MIRATI THERAPEUTICS INC | $10,178,000 | -10.1% | 295,700 | -17.8% | 0.57% | -6.9% |
RTRX | New | RETROPHIN INCcall | $10,130,000 | – | 500,000 | +100.0% | 0.56% | – |
PRTK | PARATEK PHARMACEUTICALS INC | $10,075,000 | -26.3% | 530,283 | 0.0% | 0.56% | -23.6% | |
HZNP | Sell | HORIZON PHARMA PLCcall | $9,910,000 | -74.1% | 500,000 | -54.5% | 0.55% | -73.2% |
ARDX | Sell | ARDELYX INC | $9,492,000 | +6.9% | 549,290 | -15.4% | 0.53% | +10.7% |
ADHD | Sell | ALCOBRA LTD | $9,405,000 | -9.0% | 1,557,106 | -1.4% | 0.52% | -5.8% |
NVRO | New | NEVRO CORPcall | $9,278,000 | – | 200,000 | +100.0% | 0.52% | – |
CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $9,052,000 | -34.8% | 586,117 | -33.3% | 0.50% | -32.4% |
ATRC | Sell | ATRICURE INC | $8,841,000 | -25.8% | 403,519 | -16.5% | 0.49% | -23.1% |
RPTP | Buy | RAPTOR PHARMACEUTICAL CORP | $8,549,000 | -59.0% | 1,412,995 | +7.1% | 0.48% | -57.5% |
AMRN | Buy | AMARIN CORP PLCspons adr new | $8,058,000 | -7.1% | 4,175,216 | +18.4% | 0.45% | -3.9% |
ADMA | ADMA BIOLOGICS INC | $8,061,000 | -9.7% | 964,193 | 0.0% | 0.45% | -6.7% | |
ELOS | Buy | SYNERON MEDICAL LTD | $7,545,000 | -29.3% | 1,055,221 | +5.0% | 0.42% | -26.8% |
GNCA | Buy | GENOCEA BIOSCIENCES INC | $7,167,000 | -47.6% | 1,046,243 | +5.0% | 0.40% | -45.7% |
ANTH | Sell | ANTHERA PHARMACEUTICALS ORD | $7,032,000 | -40.5% | 1,154,674 | -15.7% | 0.39% | -38.4% |
BOTA | Buy | BIOTA PHARMACEUTIALS INC | $6,904,000 | +27.7% | 3,486,711 | +33.5% | 0.38% | +32.0% |
DPRX | Sell | DIPEXIUM PHARMACEUTICALS INC | $6,524,000 | +8.0% | 465,978 | -1.9% | 0.36% | +11.7% |
CFRX | Sell | CONTRAFECT CORP | $6,312,000 | +6.0% | 1,418,439 | -0.0% | 0.35% | +9.7% |
FATE | Sell | FATE THERAPEUTICS INC | $5,938,000 | -29.4% | 1,113,986 | -14.3% | 0.33% | -27.0% |
TENX | TENAX THERAPEUTICS INC | $5,906,000 | -18.7% | 1,968,631 | 0.0% | 0.33% | -15.6% | |
SCYX | SCYNEXIS INC | $5,642,000 | -17.2% | 775,000 | 0.0% | 0.31% | -14.2% | |
IRMD | Sell | IRADIMED CORP | $5,612,000 | -32.2% | 230,358 | -35.2% | 0.31% | -29.9% |
BLRX | Buy | BIOLINERX LTDsponsored adr | $5,355,000 | -35.1% | 3,500,000 | +12.9% | 0.30% | -32.7% |
FLXN | Sell | FLEXION THERAPEUTICS INCsponsored adr | $4,803,000 | -37.0% | 323,188 | -7.2% | 0.27% | -34.9% |
TNXP | Buy | TONIX PHARMACEUTICALS HLDG C | $4,712,000 | -30.9% | 890,748 | +17.1% | 0.26% | -28.6% |
CBYL | CARBYLAN THERAPEUTICS INC | $4,209,000 | -50.1% | 1,178,941 | 0.0% | 0.23% | -48.3% | |
MDWD | Buy | MEDIWOUND LTD | $3,888,000 | +359.0% | 509,573 | +325.1% | 0.22% | +369.6% |
ARAY | Sell | ACCURAY INC | $3,746,000 | -44.4% | 750,000 | -25.0% | 0.21% | -42.5% |
VCYT | VERACYTE INC | $3,453,000 | -57.9% | 736,196 | 0.0% | 0.19% | -56.5% | |
EPRSQ | EPIRUS BIOPHARMACEUTICALS IN | $3,426,000 | -22.6% | 775,000 | 0.0% | 0.19% | -19.7% | |
CASM | CAS MED SYS INC | $3,273,000 | -2.3% | 2,618,296 | 0.0% | 0.18% | +1.1% | |
OSUR | ORASURE TECHNOLOGIES INC | $3,044,000 | -17.6% | 685,528 | 0.0% | 0.17% | -15.1% | |
DSCO | Buy | DISCOVERY LABORATORIES INC N | $2,847,000 | -46.5% | 9,489,166 | +21.3% | 0.16% | -44.8% |
CRDC | CARDICA INC | $2,396,000 | -45.9% | 8,874,992 | 0.0% | 0.13% | -44.1% | |
BIOD | Sell | BIODEL INC | $2,268,000 | -60.5% | 5,155,530 | -7.6% | 0.13% | -59.2% |
RXII | RXI PHARMACEUTICALS CORP NEW | $2,272,000 | -24.3% | 6,126,482 | 0.0% | 0.13% | -21.7% | |
APHB | New | AMPLIPHI BIOSCIENCES CORP | $2,180,000 | – | 552,000 | +100.0% | 0.12% | – |
CDTX | Buy | CIDARA THERAPEUTICS INC | $2,123,000 | +1.0% | 166,875 | +11.2% | 0.12% | +4.4% |
BVX | BOVIE MEDICAL CORP | $1,847,000 | -30.1% | 947,400 | 0.0% | 0.10% | -27.5% | |
ONTY | Sell | ONCOTHYREON | $1,623,000 | -74.5% | 592,200 | -65.2% | 0.09% | -73.7% |
RTTR | RITTER PHARMACEUTICALS INC | $1,595,000 | -53.9% | 778,000 | 0.0% | 0.09% | -52.2% | |
ZSAN | Sell | ZOSANO PHARMA CORP | $1,472,000 | -58.1% | 371,842 | -23.3% | 0.08% | -56.6% |
MELA | Buy | MELA SCIENCES INC | $1,453,000 | +229.5% | 1,274,297 | +232.2% | 0.08% | +237.5% |
BDSI | Sell | BIODELIVERY SCIENCES INTL INcall | $1,390,000 | -76.7% | 250,000 | -66.7% | 0.08% | -76.0% |
TTPH | New | TETRAPHASE PHARMACEUTICALS | $1,194,000 | – | 160,047 | +100.0% | 0.07% | – |
PTN | New | PALATIN TECHNOLOGIES INC | $1,108,000 | – | 1,368,085 | +100.0% | 0.06% | – |
TRIV | Exit | TRIVASCULAR TECHNOLOGIES INC | $0 | – | -6,032 | -100.0% | -0.00% | – |
CAPR | Exit | CAPRICOR THERAPEUTICS INC | $0 | – | -118,002 | -100.0% | -0.03% | – |
TEAR | Exit | TEARLAB CORP | $0 | – | -914,499 | -100.0% | -0.10% | – |
UNIS | Exit | UNILIFE CORP NEW | $0 | – | -1,150,000 | -100.0% | -0.13% | – |
TRNX | Exit | TORNIER N V | $0 | – | -100,000 | -100.0% | -0.13% | – |
AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -531,768 | -100.0% | -0.20% | – |
OHRP | Exit | OHR PHARMACEUTICAL INC | $0 | – | -1,775,000 | -100.0% | -0.24% | – |
PGNX | Exit | PROGENICS PHARMACEUTICALS INcall | $0 | – | -600,000 | -100.0% | -0.24% | – |
DRRX | Exit | DURECT CORP | $0 | – | -2,195,378 | -100.0% | -0.28% | – |
COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -297,200 | -100.0% | -0.28% | – |
XOMA | Exit | XOMA CORP DEL | $0 | – | -1,500,000 | -100.0% | -0.31% | – |
ABMD | Exit | ABIOMED INC | $0 | – | -100,000 | -100.0% | -0.35% | – |
VSTM | Exit | VERASTEM INC | $0 | – | -1,050,000 | -100.0% | -0.42% | – |
ZGNX | Exit | ZOGENIX INC | $0 | – | -10,737,645 | -100.0% | -0.97% | – |
ALR | Exit | ALERE INC | $0 | – | -452,423 | -100.0% | -1.28% | – |
DEPO | Exit | DEPOMED INC | $0 | – | -1,167,442 | -100.0% | -1.35% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIODELIVERY SCIENCES INTL IN | 27 | Q4 2019 | 4.8% |
HERON THERAPEUTICS INC | 24 | Q4 2019 | 9.0% |
LA JOLLA PHARMACEUTICAL CO | 24 | Q4 2019 | 7.7% |
RECRO PHARMA INC | 24 | Q4 2019 | 4.1% |
ANTARES PHARMA INC | 24 | Q3 2019 | 3.4% |
RETROPHIN INC | 23 | Q3 2019 | 7.0% |
ARATANA THERAPEUTICS INC | 22 | Q2 2019 | 8.1% |
MIRATI THERAPEUTICS INC | 22 | Q1 2019 | 7.9% |
CATALYST PHARM PARTNERS INC | 22 | Q3 2019 | 6.2% |
ANGIODYNAMICS INC | 21 | Q3 2018 | 6.6% |
View Broadfin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Eiger BioPharmaceuticals, Inc.Sold out | January 04, 2021 | 0 | 0.0% |
LA JOLLA PHARMACEUTICAL COSold out | January 04, 2021 | 0 | 0.0% |
STRATA Skin Sciences, Inc. | June 23, 2020 | 1,529,392 | 4.5% |
Teligent, Inc.Sold out | February 25, 2020 | 0 | 0.0% |
Neos Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
Aclaris Therapeutics, Inc. | February 13, 2020 | 1,888,039 | 4.6% |
Adamas Pharmaceuticals IncSold out | February 13, 2020 | 0 | 0.0% |
ADMA BIOLOGICS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
AVADEL PHARMACEUTICALS PLC | February 13, 2020 | 1,029,012 | 2.8% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
View Broadfin Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2022-03-22 |
4 | 2022-02-15 |
4 | 2022-01-31 |
4 | 2021-11-22 |
4 | 2021-11-15 |
4 | 2021-11-09 |
4 | 2021-08-10 |
4 | 2021-05-13 |
SC 13G/A | 2021-01-04 |
SC 13G/A | 2021-01-04 |
View Broadfin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.